PerkinElmer, Inc.  

(Public, NYSE:PKI)   Watch this stock  
Find more results for Human Genome Sciences Inc.�
44.27
+0.08 (0.18%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 44.00 - 44.61
52 week 29.50 - 46.72
Open 44.18
Vol / Avg. 642,461.00/772,065.00
Mkt cap 5.00B
P/E 29.92
Div/yield 0.07/0.63
EPS 1.48
Shares 112.85M
Beta 0.95
Inst. own 94%
Apr 24, 2014
Q1 2014 PerkinElmer Earnings Conference Call - 5:00PM EDT - Add to calendar
Apr 24, 2014
Q1 2014 PerkinElmer Earnings Release - 4:00PM EDT - Add to calendar
Apr 22, 2014
PerkinElmer Annual Shareholder Meeting - 10:30AM EDT - Add to calendar
Mar 5, 2014
PerkinElmer at Cowen Health Care Conference
Feb 12, 2014
PerkinElmer at Leerink Swann Global Healthcare Conference
Jan 30, 2014
Q4 2013 PerkinElmer Earnings Conference Call - Webcast
Jan 30, 2014
Q4 2013 PerkinElmer Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 11.53% 7.75%
Operating margin 14.27% 10.04%
EBITD margin - 17.62%
Return on average assets 7.04% 4.28%
Return on average equity 14.02% 8.54%
Employees 7,600 -
CDP Score - 62 D

Address

940 WINTER STREET
WALTHAM, MA 2451
United States - Map
+1-781-6635776 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. Through the Company�s advanced technologies, solutions, and services, it addresses issues related to health and safety of people and their environment. It operates in two segments: Human Health and Environmental Health. The Company�s Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and accelerate the discovery and development of critical new therapies. The Company�s Environmental Health segment provides technologies and applications to facilitate the creation of safer food and consumer products, secure surroundings and energy resources.

Officers and directors

Robert F. Friel Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Frank Anders Wilson CPA Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
Daniel R. Marshak Ph.D. Chief Scientific Officer, Senior Vice President, President - Emerging Diagnostics
Age: 55
Bio & Compensation  - Reuters
Joel S. Goldberg Senior Vice President, General Counsel, Secretary
Age: 44
Bio & Compensation  - Reuters
John R. Letcher Senior Vice President - Human Resources
Age: 51
Bio & Compensation  - Reuters
James L Corbett Senior Vice President, President - Diagnostics
Age: 50
Bio & Compensation  - Reuters
Jon DiVincenzo Senior Vice President, President - Environmental Health
Bio & Compensation  - Reuters
Maurice H. Tenney III Senior Vice President, President - Global Operations and Customer Logistics
Age: 49
Bio & Compensation  - Reuters
Andrew Okun Chief Accounting Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
Nicholas A Lopardo Lead Independent Director
Age: 66
Bio & Compensation  - Reuters